rxstat › Shortages › Etanercept

Etanercept (Rymti, Erelzi) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Oct 8, 2026

A shortage of Etanercept is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A biologic (TNF inhibitor) used to treat rheumatoid arthritis, psoriasis and other inflammatory conditions.

Products affected
0 / 2
Reports on file
2

Shortage history

2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
ERELZI
25MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02462877 · Disruption of the manufacture of the drug.
Resolved
RYMTI
50MG · SOLUTION · LUPIN PHARMA CANADA LIMITED
DIN 02530295 · ended May 28, 2026 · Disruption of the manufacture of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Etanercept to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Etanercept is classified under “IMMUNOSUPPRESSANTS” (ATC L04AB).

Recent changes

Common questions

What is Etanercept used for?

A biologic (TNF inhibitor) used to treat rheumatoid arthritis, psoriasis and other inflammatory conditions.

When will Etanercept be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Etanercept in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (immunosuppressants)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Abatacept (Orencia) No current shortage Azathioprine (Imuran) No current shortage Belimumab (Benlysta) No current shortage Ixekizumab (Taltz) No current shortage Mycophenolic Acid No current shortage Siltuximab (Sylvant) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.